A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction

Background: Despite high patency rates, primary angioplasty for myocardial infarction does not necessarily result in optimal myocardial reperfusion and limitation of infarct size. Experimentally, trimetazidine limits infarct size, decreases platelet aggregation, and reduces leukocyte influx into the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cardiology 2001-02, Vol.77 (2), p.263-273
Hauptverfasser:	Steg, Ph.Gabriel, Grollier, Gilles, Gallay, Pierre, Morice, Marie-Claude, Karrillon, Gaëtan J., Benamer, Hakim, Kempf, Christian, Laperche, Thierry, Arnaud, Pierre, Sellier, Philippe, Bourguignon, Christian, Harpey, Catherine
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Angioplasty Angioplasty, Balloon, Coronary Antianginal agents. Coronary vasodilator agents Biological and medical sciences Cardiovascular system Chemotherapy, Adjuvant Coronary Angiography Double-Blind Method Female Humans Infusions, Intravenous Male Medical sciences Middle Aged Myocardial infarction Myocardial Infarction - drug therapy Myocardial Infarction - therapy Pharmacology. Drug treatments Reperfusion ST-segment Trimetazidine Trimetazidine - administration & dosage Trimetazidine - therapeutic use Vasodilator Agents - administration & dosage Vasodilator Agents - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!